Sam Bankman-Fried Praises TrumpRx, Calls Out Insurance Giants
Share:
Sam Bankman-Fried praised the TrumpRx platform as a positive development in drug pricing. Launched on February 5, TrumpRx connects patients with drug companies for discounted medications, eliminating middlemen. Critics argue it functions more like a coupon site than a genuine healthcare solution.
Predictions Markets
See what traders are focused on
- Sam Bankman-Fried called the platform a “huge step in the right direction.”
- TrumpRx connects patients directly with drug companies offering discounted meds.
- Critics say TrumpRx is more of a coupon site than a real healthcare fix.
Sam Bankman-Fried, the former CEO of FTX, reemerged publicly on February 23 with a post on X praising the Trump administration’s new drug-pricing platform, TrumpRx. He claimed drug companies are ripping Americans off and called the platform a “huge step in the right direction.”
Bankman-Fried also pushed for insurance companies to get on board so people don’t have to pick between cheaper meds and keeping their coverage.
TrumpRx is a government-run website that launched on February 5. It connects patients directly with drug companies offering discounted meds, with no insurance or middlemen required. The site doesn’t sell anything…
Read The Full Article Sam Bankman-Fried Praises TrumpRx, Calls Out Insurance Giants On Coin Edition.
Predictions Markets
See what traders are focused on
Share:
Predictions Markets
See what traders are focused on
Share:
Read More
Trump Faces Fresh Scrutiny Over Finances and Crypto Ties
